CNNMoney.com
Companies Economy International Corrections Pre-market trading After-hours trading Winners/losers/actives Bonds Currencies Commodities Money Magazine Retirement Mutual Funds Taxes Ask the Expert Money 101 Autos Loan Center Best Places to Live Calculators Mortgage Rates Personal tech Big Tech blog Techland blog Sectors and stocks Fortune 500 techs Tech Talk 100 best places to launch Ultimate resource guide Small biz makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management Rankings Main Create portfolio Edit portfolio Create Alerts Edit Alerts
More Galleries
The world's priciest foods Jamón ibérico de bellota, newly legal for import (at $180 per pound), barely cracks the top five on the pricey foods scale. We checked in with gourmet retailers for the rundown on the world's most expensive culinary indulgences. (more)
Small shop saves town When chain stores shunned tiny Powell, Wyo., the town's residents took a DIY approach and built the Powell Mercantile themselves - and, in the process, revitalized their dying downtown. (more)
Recession concessions From Padre's "free drink with foreclosure notice" special in Phoenix to NYC's famed Gray's Papaya $3.50 Recession Special, these restaurants and bars are profiting from penny-pinching specials. (more)

8 of 36
BACK NEXT
Taking the sting out of canker sores
Taking the sting out of canker sores
Stephen Patterson, Patrick Gosselin, Matt Cara and Stephanie Bowen
•  enexra  video
Team name: AiB Pharma

School name: Texas A&M University, Mays Business School

Team members: Patrick Gosselin, Stephen Patterson, Matt Cara, Stephanie Bowen

Concept: Canker sores might hurt a little, but they hurt a lot of people. By one estimate, the tiny mouth ulcers make 20% of the population miserable. So far, no one has figured out what causes them or how to cure them. Available products that claim to reduce the pain and duration of the sores are often so nasty that about 80% of afflicted people choose to grimace and bear the pain without attempting treatment.

The members of AiB Pharma believe a chemical cocktail invented by Dr. Phil Campbell (who serves as an advisor to the company), a professor at the Baylor College of Dentistry, can soothe millions of mouths and make this early-stage pharmaceutical company millions of dollars. A double blind study at Baylor showed the product's efficacy to be "statistically significant," while 14 private practice dentists used the formula on more than 2,000 patients with "enormous success." The company claims the drug speeds healing by up to 86%.

Timeline: The founders of AiB Pharma believe they can have a product on the market in about four years. - Shara Rutberg

NEXT: A nanotherapy for liver cancer

Last updated May 02 2008: 11:51 AM ET
© 2008 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2008 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. All Times are ET.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Hemscott.
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.